Biogen Ventures Into Value-Based Contracts In Multiple Sclerosis
Executive Summary
Four contracts test approaches tying reimbursement to relapse rates and discontinuation of treatment. Payers involved include Harvard Pilgrim and Intermountain's SelectHealth.